Background: Human herpesvirus 6 (HHV-6) infection occurs worldwide and can be reactivated from latency during periods of immunosuppression, especially after organ transplantation. No previous study has evaluated the influence of dialysis type on HHV-6 infection. The aim of the present study was to determine the prevalence of HHV-6 antibodies in hemodialysis (HD) and peritoneal dialysis (PD) patients.
Methods: We studied 36 PD patients, 35 HD patients, and 20 healthy subjects, all with no history of organ transplantation. After systematic inquiries and a physical examination, blood was drawn for determination of biochemical parameters, cytomegalovirus immunoglobulin M (IgM) and immunoglobulin G (IgG), hepatitis B surface antigen, and the hepatitis C and human immunodeficiency virus antibodies. Titers of HHV-6 IgM and IgG antibodies were determined by ELISA.
Results: Titers for HHV-6 IgM antibody were positive in 9 HD patients (25.7%), 8 PD patients (22.2%), and 2 control subjects (10.0%, p > 0.05). More HD patients (20.0%) than PD patients (5.6%, p = 0.07) or control subjects (0.0%, p = 0.03) were positive for HHV-6 IgG antibody. In HD patients, HHV-6 IgG seropositivity and duration of dialysis were positively correlated (R = 0.33, p = 0.05).
Conclusions: Infection with HHV-6 is not rare in PD and HD patients. In addition, HHV-6 IgG seropositivity was significantly higher in HD patients than in control subjects and approached significance when compared with seropositivity in PD patients. Moreover, in HD patients, HHV-6 IgG seropositivity correlated with duration on HD. These preliminary findings provide insight into the pre-transplantation period for patients and may aid our understanding of how to best protect patients against HHV-6 after transplantation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3747/pdi.2010.00093 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms.
J Adv Res
November 2024
Immunosciences Lab, Inc., Los Angeles, CA 90035, USA; Cyrex Laboratories, LLC, Phoenix, AZ 85034, USA.
Article Synopsis
- Long COVID is linked to autoimmune responses that affect neural proteins, contributing to conditions like fatigue and mood disorders.
- In a study, researchers measured various immunoglobulin antibodies in Long COVID patients versus healthy controls, finding significant increases in specific antibodies associated with neuronal proteins.
- The findings suggest brain-targeted autoimmunity plays a key role in Long COVID, influencing both physical and psychological symptoms, with certain antibodies serving as strong predictors for the condition's severity.
Human Herpesvirus-6B Infection and Alterations of Gut Microbiome in Patients with Fibromyalgia: A Pilot Study.
Biomolecules
October 2024
The Institute of Microbiology and Virology of the Riga Stradiņš University Science Hub, LV-1067 Riga, Latvia.
Article Synopsis
- * The study included 17 FM patients and 24 healthy individuals, aiming to identify potential biomarkers, detecting human herpesvirus (HHV)-6A and B in patient samples, and measuring related antibodies and cytokine levels.
- * Findings indicated higher detection of HHV-6B in FM patients, particularly those with a BMI of 30 or more, along with significant differences in gut microbiome diversity between FM patients and healthy controls.
From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
J Med Virol
August 2024
Immunosciences Lab Inc., Los Angeles, California, USA.
Article Synopsis
- Long COVID is linked to inflammation and autoimmune responses, particularly involving tight junction proteins and immune reactions to bacterial components, which manifest as symptoms of chronic fatigue and emotional distress known as the "physio-affective phenome."
- A study involving 90 Long COVID patients and 90 healthy controls focused on various immune responses related to SARS-CoV-2 and other proteins, revealing key immune markers associated with Long COVID diagnosis.
- Findings indicated that autoimmune responses, particularly against tight junction proteins, significantly correlated with indicators of human herpes virus-6 reactivation and contributed to the overall symptoms experienced in Long COVID.
Antibody immune responses and causal relationships in four immune skin diseases: Evidence from Mendelian randomization and Bayesian Weighting (Antibody Responses in Skin Diseases: MR & Bayesian).
Skin Res Technol
August 2024
Clinical Medical College, Jiangxi University of Chinese Medicine, Nanchang, China.
Background: Recent studies increasingly suggest that microbial infections and the immune responses they elicit play significant roles in the pathogenesis of chronic inflammatory skin diseases. This study uses Mendelian randomization (MR) and Bayesian weighted Mendelian randomization (BWMR) to explore the causal relationships between immune antibody responses and four common skin diseases: psoriasis, atopic dermatitis (AD), rosacea, and vitiligo.
Methods: We utilized summary statistics from genome-wide association studies (GWAS) for antibody responses to 13 infectious pathogens and four skin diseases.
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.
Front Immunol
June 2024
Grupo de Investigación de Factores Ambientales en Enfermedades Degenerativas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Red de Enfermedades Inflamatorias (REI), Madrid, Spain.
Background: Although fingolimod, a sphingosine 1-phosphate receptor agonist, has shown to be an effective treatment reducing relapse rate and also slowing down the disability progression in relapsing-remitting multiple sclerosis (RRMS) patients, it is important to quickly identify those suboptimal responders.
Objective: The main objective was to assess different clinical, radiological, genetic and environmental factors as possible early predictors of response in MS patients treated with fingolimod for 24 months. The secondary objective was to analyze the possible contribution of the environmental factors analyzed to the progression and activity of the disease along the 2-years of follow-up.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!